Carcinogenesis, Vol. 22, No. 8, 1195-1199,
August 2001
© 2001 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case–control study
1 Department of Epidemiology and
2 Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holocombe Boulevard, Houston, TX 77030, USA
A G
A polymorphism (G870A) in exon 4 of the cyclin D1 (CCND1) gene creates an alternative splice site in its mRNA, encoding a protein with an altered C-terminal domain. It has been suggested that DNA damage in cells with the A allele bypasses the G1/S checkpoint of the cell cycle more easily than damage in cells without the A allele. Because CCND1 plays a critical role in cell cycle control and reduced DNA repair capacity is associated with an increased risk for squamous cell carcinoma of the head and neck (SCCHN), we hypothesize that this CCND1 polymorphism modulates individual susceptibility to SCCHN. To test this hypothesis we evaluated the frequency of the polymorphism in a hospital-based case–control study of 233 newly diagnosed SCCHN patients and 248 non-cancer controls. The cases and controls were frequency matched by age (±5 years), sex and tobacco use. All subjects were non-Hispanic whites. We found that the A allele frequency was slightly higher in the cases (0.485) than in the controls (0.425), but the difference was borderline statistically significant (P = 0.064). The frequencies of the CCND1 AA, GA and GG genotypes were 23.6, 49.8 and 26.6%, respectively, in cases and 16.5, 52.5 and 31.5%, respectively, in controls. Multivariate logistic regression analysis adjusting for age (in years), sex, smoking and alcohol use was performed to calculate odds ratios (OR) and 95% confidence intervals (CI). Compared with the wild-type CCND1 GG, the CCND1 A G genotype was associated with a non-significantly increased risk (adjusted OR 1.15, 95% CI 0.75–1.76), but the CCND1 AA genotype was associated with a significantly increased risk (adjusted OR 1.77, 95% CI 1.04–3.02) for SCCHN. Results from a trend test using a logistic regression model were statistically significant (P = 0.044). Among the cases the mean age of onset was 59.0, 56.8 and 55.5 years for the GG, GA and AA genotypes, respectively. In the stratification analysis the CCND1 AA variant genotype was associated with a >3-fold increased risk in individuals who were 
50 years old (OR 3.18, 95% CI 1.19–8.46), females (3.57, 1.26–10.0), non-smokers (3.71, 1.37–10.1) and non-alcohol users (4.76, 1.61–14.0). These results suggest that the CCND1 polymorphism is associated with early onset of SCCHN and contributes to susceptibility to SCCHN in this population.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. J. Freemantle, Y. Guo, and E. Dmitrovsky Retinoid Chemoprevention Trials: Cyclin D1 in the Crosshairs Cancer Prevention Research, January 1, 2009; 2(1): 3 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Gupta, A. Feber, L. Xi, A. Pennathur, M. Wu, J. D. Luketich, and T. E. Godfrey Association between CCND1 G/A870 Polymorphism, Allele-Specific Amplification, Cyclin D1 Expression, and Survival in Esophageal and Lung Carcinoma Clin. Cancer Res., December 1, 2008; 14(23): 7804 - 7812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pabalan, B. Bapat, L. Sung, H. Jarjanazi, O. Francisco-Pabalan, and H. Ozcelik Cyclin D1 Pro241Pro (CCND1-G870A) Polymorphism Is Associated with Increased Cancer Risk in Human Populations: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2773 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Marsit, C. C. Black, M. R. Posner, and K. T. Kelsey A Genotype-Phenotype Examination of Cyclin D1 on Risk and Outcome of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., April 15, 2008; 14(8): 2371 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Han, J.H. No, Y.T. Jeon, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2 Hum. Reprod., March 1, 2008; 23(3): 525 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Driver, H. Song, F. Lesueur, S. Ahmed, N. L. Barbosa-Morais, J. P. Tyrer, B. A.J. Ponder, D. F. Easton, P. D.P. Pharoah, A. M. Dunning, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population Carcinogenesis, February 1, 2008; 29(2): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Izzo, T.-T. Wu, X. Wu, J. Ensor, R. Luthra, J. Pan, A. Correa, S. G. Swisher, C. K.S. Chao, W. N. Hittelman, et al. Cyclin D1 Guanine/Adenine 870 Polymorphism With Altered Protein Expression Is Associated With Genomic Instability and Aggressive Clinical Biology of Esophageal Adenocarcinoma J. Clin. Oncol., February 20, 2007; 25(6): 698 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, Z. Liu, E. M. Sturgis, Q. Shi, R. M. Chamberlain, M. R. Spitz, and Q. Wei Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2005; 26(9): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ceschi, C.-L. Sun, D. Van Den Berg, W.-P. Koh, M. C. Yu, and N. Probst-Hensch The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore Carcinogenesis, August 1, 2005; 26(8): 1457 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sadetzki, P. Flint-Richter, S. Starinsky, I. Novikov, Y. Lerman, B. Goldman, and E. Friedman Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. O. Shu, D. B. Moore, Q. Cai, J. Cheng, W. Wen, L. Pierce, H. Cai, Y.-T. Gao, and W. Zheng Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 91 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Le Marchand, A. Seifried, A. Lum-Jones, T. Donlon, and L. R. Wilkens Association of the Cyclin D1 A870G Polymorphism With Advanced Colorectal Cancer JAMA, December 3, 2003; 290(21): 2843 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lu, A. B. Gladden, and J. A. Diehl An Alternatively Spliced Cyclin D1 Isoform, Cyclin D1b, Is a Nuclear Oncogene Cancer Res., November 1, 2003; 63(21): 7056 - 7061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qiuling, Z. Yuxin, Z. Suhua, X. Cheng, L. Shuguang, and H. Fengsheng Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population Carcinogenesis, September 1, 2003; 24(9): 1499 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Izzo, V. A. Papadimitrakopoulou, D. D. Liu, P. L. C. den Hollander, I. M. Babenko, J. Keck, A. K. El-Naggar, D. M. Shin, J. J. Lee, W. K. Hong, et al. Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract Cancer J Natl Cancer Inst, February 5, 2003; 95(3): 198 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yu, W. Lu, W. Tan, D. Xing, G. Liang, X. Miao, and D. Lin Lack of Association between CCND1 G870A Polymorphism and Risk of Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 176 - 176. [Full Text] [PDF]
|
|
|
|
|
|
Y. Zheng, H. Shen, E. M. Sturgis, L.-E Wang, S. Shete, M. R. Spitz, and Q. Wei Haplotypes of Two Variants in p16 (CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 640 - 645. [Abstract] [Full Text] [PDF]
|
|